TearLab Launches Free Smartphone Investor Relations App

Published 2:50 PM ET Tue, 9 April 2013
Globe Newswire

SAN DIEGO, Calif., April 9, 2013 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") today announced that its smartphone investor relations application is now available for free download through Apple's App Store.

"The TearLab IR App was designed by Innovasium Digital to provide the investment community with direct and real-time mobile access to Company news and information," commented Elias Vamvakas, TearLab's Chief Executive Officer. "We hope and trust it will prove to be an essential new tool for shareholders, analysts and potential investors as they monitor our progress."

About TearLab Corporation

TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab® Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.

About Innovasium Digital

Innovasium creates custom digital experiences focused on the healthcare and investor relations industries. Since 2000, Innovasium has been delivering high-impact, responsive websites, mobile apps, and social media experiences that help clients extend their reach and engage customers online. Innovasium's proprietary software platforms iCMS, Merchant and ADAPT accelerate development, decrease operating costs, and enable clients to connect digitally with their customers. Get started at www.innovasium.com.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about TearLab. Examples of forward-looking statements in this press release include statements regarding future success and the related impact on our sales. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our annual and quarterly reports on Forms 10-K and 10-Q. We do not undertake to update any forward-looking statements.